L1Z1 Stock Overview A medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. More details
Rewards Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
Alphatec Holdings, Inc. Competitors Price History & Performance
Summary of share price highs, lows and changes for Alphatec Holdings Historical stock prices Current Share Price US$8.30 52 Week High US$15.30 52 Week Low US$4.36 Beta 1.39 1 Month Change -6.74% 3 Month Change 55.14% 1 Year Change -38.52% 3 Year Change -20.95% 5 Year Change 27.69% Change since IPO 244.11%
Recent News & Updates
Alphatec Holdings, Inc. Revises Earnings Guidance for the Year Ended December 31, 2024 Nov 02
Third quarter 2024 earnings released: US$0.28 loss per share (vs US$0.35 loss in 3Q 2023) Nov 01
Alphatec Holdings, Inc. to Report Q3, 2024 Results on Oct 30, 2024 Oct 07
New major risk - Share price stability Oct 02
Insider recently bought €255k worth of stock Aug 23
New minor risk - Profitability Aug 06 See more updates
Alphatec Holdings, Inc. Revises Earnings Guidance for the Year Ended December 31, 2024 Nov 02
Third quarter 2024 earnings released: US$0.28 loss per share (vs US$0.35 loss in 3Q 2023) Nov 01
Alphatec Holdings, Inc. to Report Q3, 2024 Results on Oct 30, 2024 Oct 07
New major risk - Share price stability Oct 02
Insider recently bought €255k worth of stock Aug 23
New minor risk - Profitability Aug 06
New minor risk - Profitability Aug 02
New major risk - Share price stability Aug 01
Second quarter 2024 earnings released: US$0.28 loss per share (vs US$0.43 loss in 2Q 2023) Aug 01
Alphatec Holdings, Inc. Revises Earnings Guidance for the Year Ending December 31, 2024 Aug 01
Alphatec Holdings, Inc. Launches Eos Insighttm, an End-To-End Spine Surgery Platform Powered by Eos Imaging and Ai Jul 24
Alphatec Holdings, Inc. to Report Q2, 2024 Results on Jul 31, 2024 Jul 11
General Counsel & Corporate Secretary recently sold €504k worth of stock Jun 16
New major risk - Financial position May 15
Alphatec Holdings, Inc. Revises Earnings Guidance for the Fiscal Year Ended December 31, 2024 May 09
First quarter 2024 earnings released: US$0.34 loss per share (vs US$0.40 loss in 1Q 2023) May 08
Alphatec Holdings, Inc., Annual General Meeting, Jun 12, 2024 Apr 28
Alphatec Holdings, Inc. to Report Q1, 2024 Results on May 07, 2024 Apr 19
Independent Director recently bought €235k worth of stock Mar 13
New minor risk - Profitability Mar 01
Alphatec Holdings, Inc. Provides Revenue Guidance for Fiscal Year Ending December 31, 2024 Feb 29
Full year 2023 earnings released: US$1.54 loss per share (vs US$1.47 loss in FY 2022) Feb 28
Alphatec Holdings, Inc. to Report Fiscal Year 2023 Results on Feb 27, 2024 Jan 09
Alphatec Holdings, Inc. Provides Revenue Guidance for Full-Year 2024 Jan 08
Insider recently bought €294k worth of stock Nov 14
Alphatec Holdings, Inc. Provides Earnings Guidance for the Fiscal Year Ending December 31, 2023 Nov 08
Third quarter 2023 earnings released: US$0.35 loss per share (vs US$0.35 loss in 3Q 2022) Nov 07
New major risk - Share price stability Oct 25 Alphatec Holdings, Inc. Provides Earnings Guidance for the Three Months Ended September 30, 2023 Alphatec Holdings, Inc. Appoints Dave Demski as an Independent Director to the Board Alphatec Holdings, Inc. to Report Q3, 2023 Results on Nov 06, 2023
Insider recently sold €480k worth of stock Sep 15
Alphatec Holdings, Inc. Provides Earnings Guidance for the Fiscal Year Ended December 31, 2023 Aug 04
Second quarter 2023 earnings released: US$0.43 loss per share (vs US$0.36 loss in 2Q 2022) Aug 04
New major risk - Financial position Jul 10
Insider recently sold €1.0m worth of stock Jun 19
Insider recently bought €51k worth of stock May 15
No longer forecast to breakeven May 09
First quarter 2023 earnings released: US$0.40 loss per share (vs US$0.43 loss in 1Q 2022) May 06
Alphatec Holdings, Inc. Provides Earnings Guidance for the Year Ending December 31, 2023 May 06
Forecast to breakeven in 2025 May 01
Forecast to breakeven in 2025 Apr 21
Insider recently bought €68k worth of stock Mar 16
No longer forecast to breakeven Mar 03
Full year 2022 earnings released: US$1.47 loss per share (vs US$1.50 loss in FY 2021) Mar 01
Forecast to breakeven in 2025 Feb 16
Executive Chairman recently sold €2.2m worth of stock Jan 22 Alphatec Holdings, Inc. to Report Q4, 2022 Results on Feb 28, 2023
Forecast to breakeven in 2025 Dec 31
Third quarter 2022 earnings released: US$0.35 loss per share (vs US$0.43 loss in 3Q 2021) Nov 05
Alphatec Holdings, Inc. Provides Earnings Guidance for the Full Year Ending December 31, 2022 Nov 04
ATEC Launches Expandable Technology for Medialized Posterior Procedure Oct 13
Alphatec Holdings, Inc. Advances Lateral Sophistication Oct 12 Alphatec Holdings, Inc. Provides Revenue Guidance for the Third Quarter Ended September 30, 2022 and Full Year of 2022
Alphatec Holdings, Inc. Provides Revenue Guidance for the Full Year of 2022 Aug 06
Second quarter 2022 earnings released: US$0.36 loss per share (vs US$0.39 loss in 2Q 2021) Aug 05
Alphatec Holdings, Inc. to Report Q2, 2022 Results on Aug 04, 2022 Jul 22
Insider recently bought €664k worth of stock Jun 17
Alphatec Holdings, Inc. Elects Andy S. Barnett on the Board of Directors Jun 17
Executive VP of People & Culture recently sold €470k worth of stock Jun 07
No longer forecast to breakeven Jun 02
Alphatec Holdings, Inc. Revises Revenue Guidance for the Fiscal Year Ended December 31, 2022 May 06
Alphatec Holdings, Inc. to Report Q1, 2022 Results on May 05, 2022 Apr 22
Alphatec Holdings, Inc. announced delayed annual 10-K filing Mar 04
Full year 2021 earnings: Revenues and EPS in line with analyst expectations Mar 03
Alphatec Holdings, Inc. Provides Revenue Guidance for the Fiscal Year Ending December 31, 2022 Mar 03
Forecast to breakeven in 2024 Feb 02
Alphatec Holdings Provides Revenue Guidance for Fiscal Ending December 31, 2022 Jan 12
Insider recently bought €1.7m worth of stock Nov 29
Insider recently bought €61k worth of stock Nov 12
Third quarter 2021 earnings released: US$0.43 loss per share (vs US$0.24 loss in 3Q 2020) Nov 06
Independent Director Donald Williams has left the company Aug 18
Second quarter 2021 earnings released: US$1.31 loss per share (vs US$0.25 loss in 2Q 2020) Aug 04
Alphatec Holdings, Inc. Provides Revenue Guidance for the Second Quarter Ended June 30, 2021 Jul 14
Executive Vice President of Sales recently sold €122k worth of stock Jun 22
Insider recently bought €1.5m worth of stock May 14
First quarter 2021 earnings released: US$0.26 loss per share (vs US$0.33 loss in 1Q 2020) May 08
Alphatec Holdings, Inc. Provides Earnings Guidance for the Year 2021 May 07
Executive Officer has left the company May 01
Alphatec Holdings, Inc. Reports Preliminary Revenue Results for the First Quarter Ended March 31, 2021 Apr 09
Alphatec Holdings, Inc. Announces the Launch of the InVictus® Occipital-Cervical-Thoracic (OCT) Spinal Fixation System Mar 16
Insider recently bought €62k worth of stock Mar 15
Full year 2020 earnings released: US$1.18 loss per share (vs US$1.09 loss in FY 2019) Mar 07
Revenue beats expectations Mar 07
New 90-day high: €13.80 Mar 04
New 90-day high: €13.10 Feb 10
New 90-day high: €12.10 Jan 22
Alphatec Holdings, Inc. to Report Q4, 2020 Results on Mar 04, 2021 Jan 13
New 90-day high: €11.90 Jan 05
Alphatec Holdings, Inc. (NasdaqGS:ATEC) agreed to acquire EOS imaging SA (ENXTPA:EOSI) for $79.5 million. Dec 18 Shareholder Returns L1Z1 DE Medical Equipment DE Market 7D -11.7% -2.9% -2.6% 1Y -38.5% -8.5% 6.9%
See full shareholder returns
Return vs Market: L1Z1 underperformed the German Market which returned 7.1% over the past year.
Price Volatility Is L1Z1's price volatile compared to industry and market? L1Z1 volatility L1Z1 Average Weekly Movement 13.4% Medical Equipment Industry Average Movement 6.6% Market Average Movement 4.8% 10% most volatile stocks in DE Market 11.3% 10% least volatile stocks in DE Market 2.4%
Stable Share Price: L1Z1's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: L1Z1's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. It manufactures and sells implants and instruments through third-party suppliers. The company offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application, which leverages EOS technology to more quickly quantify alignment parameters on a mobile device; SafeOp Neural InformatiX System that automates electromyographic and somatosensory evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems.
Show more Alphatec Holdings, Inc. Fundamentals Summary How do Alphatec Holdings's earnings and revenue compare to its market cap? L1Z1 fundamental statistics Market cap €1.20b Earnings (TTM ) -€170.47m Revenue (TTM ) €548.91m
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) L1Z1 income statement (TTM ) Revenue US$572.74m Cost of Revenue US$174.88m Gross Profit US$397.86m Other Expenses US$575.73m Earnings -US$177.87m
Last Reported Earnings
Sep 30, 2024
Earnings per share (EPS) -1.25 Gross Margin 69.47% Net Profit Margin -31.06% Debt/Equity Ratio 2,372.8%
How did L1Z1 perform over the long term?
See historical performance and comparison
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2024/12/20 07:19 End of Day Share Price 2024/12/20 00:00 Earnings 2024/09/30 Annual Earnings 2023/12/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Alphatec Holdings, Inc. is covered by 28 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Matt Miksic Barclays Gregory Chodaczek Boenning & Scattergood, Inc. William Plovanic Canaccord Genuity
Show 25 more analysts 
